Total Parathyroidectomy with Forearm Autotransplantation as the Treatment of Choice for Secondary Hyperparathyroidism

被引:23
作者
Naranda, J. [1 ,2 ]
Ekart, R. [1 ,3 ]
Pedcovnik-Balon, B. [1 ,2 ]
机构
[1] Univ Maribor, Fac Med, SI-2000 Maribor, Slovenia
[2] Univ Clin Ctr Maribor, Dept Nephrol, Maribor, Slovenia
[3] Univ Clin Ctr Maribor, Dial Dept, Maribor, Slovenia
关键词
CHRONIC KIDNEY DISEASE; HYPERPARATHYROIDISM; MINERAL AND BONE DISEASE; CALCIFICATION; PARATHYROIDECTOMY; MINERAL METABOLISM; BONE MINERAL DENSITY; CALCIUM-SENSING RECEPTOR; CHRONIC-RENAL-FAILURE; SUBTOTAL PARATHYROIDECTOMY; KIDNEY-DISEASE; HORMONE LEVELS; BONE-DISEASE; SHORT-TERM; HEMODIALYSIS; MANAGEMENT; PHOSPHATE;
D O I
10.1177/147323001103900333
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Chronic kidney disease-mineral and bone disease (CKD-MBD) is associated with uraemic bone disease, vascular calcification, reduced quality of life and reduced survival. This study evaluated the efficacy of parathyroidectomy (PTX) with autotransplantation in improving short-term and long-term outcomes. Dialysis patients who underwent PTX showed significantly more favourable biochemical parameters after PTX. These changes were accompanied by a lower coronary artery calcification score, reduced thickness of the intimae media and comparable bone mineral density measures compared with control dialysis patients who did not undergo PTX. Despite the risk of a substantially lower intact parathyroid hormone level postoperatively that might lead to adynamic bone disease, none of the patients reported clinical signs of this disease, such as bone pain or fractures. In conclusion, PTX with autotransplantation led to improvement of CKD-MBD so may be considered in patients with secondary hyperparathyroidism that is resistant to treatment with vitamin D analogues and calcimimetics.
引用
收藏
页码:978 / 987
页数:10
相关论文
共 44 条
  • [1] Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism
    Abdelhadi, M
    Nordenstrom, J
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (11) : 3845 - 3851
  • [2] QUANTIFICATION OF CORONARY-ARTERY CALCIUM USING ULTRAFAST COMPUTED-TOMOGRAPHY
    AGATSTON, AS
    JANOWITZ, WR
    HILDNER, FJ
    ZUSMER, NR
    VIAMONTE, M
    DETRANO, R
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 15 (04) : 827 - 832
  • [3] Adynamic bone in patients with chronic kidney disease
    Andress, D. L.
    [J]. KIDNEY INTERNATIONAL, 2008, 73 (12) : 1345 - 1354
  • [4] Berkoben M, INDICATIONS PARATHYR
  • [5] Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study
    Block, GA
    Hulbert-Shearon, TE
    Levin, NW
    Port, FK
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) : 607 - 617
  • [6] FACTORS IN THE DEVELOPMENT OF SECONDARY HYPERPARATHYROIDISM DURING GRADED RENAL-FAILURE IN THE RAT
    BOVER, J
    RODRIGUEZ, M
    TRINIDAD, P
    JARA, A
    MARTINEZ, ME
    MACHADO, L
    LLACH, F
    FELSENFELD, AJ
    [J]. KIDNEY INTERNATIONAL, 1994, 45 (04) : 953 - 961
  • [7] Role of the calcium-sensing receptor in parathyroid gland physiology
    Chen, RA
    Goodman, WG
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2004, 286 (06) : F1005 - F1011
  • [8] Parathyroidectomy in chronic renal failure: Short- and long-term results on parathyroid function, blood pressure and anemia
    Coen, G
    Calabria, S
    Bellinghieri, G
    Pecchini, F
    Conte, F
    Chiappini, MG
    Ferrannini, M
    Lagona, C
    Mallamace, A
    Manni, M
    DiLuca, M
    Sardella, D
    Taggi, F
    [J]. NEPHRON, 2001, 88 (02): : 149 - 155
  • [9] Control of hyperphosphatemia among patients with ESRD
    Coladonato, JA
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 : S107 - S114
  • [10] Cozzolino M, 2009, CLIN NEPHROL, V71, P593